MedPath

Effect of reperfusion on infarct size and cardiac function evaluated with MRI and echocardiography/Effekt av reperfusion på infarktstorlek och hjärtfunktion utvärderat med MR och ultraljud - Infarct_MRI_adenosi

Conditions
Patients recovering 6weeks after primary PCI for ST-elevation Myocardial Infarction.This application concerns the use of gadolinium contrast to visualise myocardial infarct size using MRI. Adenosine will be used as a physiological adjunct to better determine the presence of ischemia as well as infarction.
Registration Number
EUCTR2005-001529-27-SE
Lead Sponsor
Jan Engvall
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
140
Inclusion Criteria

Patients who have undergone primary PCI for STEMI.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Contraindications for MRI: pacemaker/ICD, intracranial clips, claustrophobia, not willing to participate

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: Objective infarct sizing after PCI for STEMI, related to the time between start of chest pain and opening up of the infarct related artery.;Secondary Objective: Detect possible remaining ischemia by observing a delayed wash-in of gadolinium during adenosin infusion.;Primary end point(s): Infarct size at the time of study.<br><br>Ischemia at adenosine infusion.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath